Skip to main content
Clinical Trials/NCT06888999
NCT06888999RecruitingNot Applicable

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 site in 1 country118 target enrollmentStarted: November 17, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
118
Locations
1
Primary Endpoint
Time to RTW

Study Overview

Brief Summary

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.

Detailed Description

This study evaluates the effectiveness of in vitro exposure to the workplace by means of VR to decrease time to RTW of sick-listed flight cabin crew with mental health related complaints compared to usual care. The study design is a pilot randomized controlled trial, including an intervention and control group. Sick-listed workers in the control group receive care as usual from the occupational physician and a psychologist. Sick-listed workers in the intervention group receive care as usual from the occupational physician and a psychologist and participate in a VR-session. During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace. Data on the primary outcome of RTW is collected based on the register data from the occupational health service (6 and 12 months after baseline). Data on secondary outcomes (self-efficacy, cognitions regarding RTW and job anxiety) is collected with baseline and follow-up questionnaires (4 months after baseline).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Masking Description

Due to the intervention, it is not possible to blind researchers, case provides, investigators and participants.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •- sick listed cabin crew with mental health related complaints that are referred by the occupational physician to a specific psychotherapist practice

Exclusion Criteria

  • •vestibular disorder
  • •no signed informed consent

Arms & Interventions

Care as usual plus VR

Experimental

Participants in the intervention group receive care as usual from the occupational physician and a psychologist and participate (al least once) in a VR-session. During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace.

Intervention: In vitro exposure to workplace by VR plus care as usual (Other)

Care as usual

Active Comparator

Participants in the care as usual group receive care as usual from the occupational physician and a psychologist.

Intervention: Care as usual: Guidance from occupational physician and psychologist focused on returning to work (Other)

Outcomes

Primary Outcomes

Time to RTW

Time Frame: 6 months and 12 months after baseline

Time between start of sickness absence until participant is considered 'fit to fly' by the occupational physician, measured by register data from the occupational health service.

Secondary Outcomes

  • Stress-related complaints(Baseline and 4-months follow-up)
  • Self-efficacy regarding return to work(Baseline and 4-months follow-up)
  • Attitude regarding return to work(Baseline and 4-months follow-up)
  • Job anxiety(Baseline and 4-months follow-up)
  • Self-efficacy regarding return to work(Baseline and 4-months follow-up)
  • Stress-related complaints(Baseline and 4-months follow-up)
  • Attitude regarding return to work(Baseline and 4-months follow-up)
  • Job anxiety(Baseline and 4-months follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Roosmarijn Schelvis

Principal Investigator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Sites (1)

Loading locations...

Similar Trials